Condition
Pre-Eclampsia; Mild
Total Trials
7
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed3
Not Yet Recruiting1
Active Not Recruiting1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07752056Not ApplicableNot Yet Recruiting
Low-Sodium Diet for Postpartum Blood Pressure Control
NCT07263490Recruiting
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
NCT06373367Not ApplicableActive Not Recruiting
Preeclampsia Educational Program Study (PrEPS)
NCT06712550Completed
Assessment of Maternal and Fetal Serum Biomarkers in Women With Pre-eclampsia
NCT03815110Completed
Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
NCT03323762Not ApplicableCompletedPrimary
Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia
NCT03262961Phase 2UnknownPrimary
Use of Sildenafil Citrate in Management of Mild Pre-eclampsia
Showing all 7 trials